Bioethics News

Low-Value Treatments, Prescriptions Common, Survey Finds

December 7, 2016

(Medscape) – Overuse of antibiotics, aggressive nonpalliative end-of-life care, chronic pain medications, and dietary supplements offer patients the least value despite widespread use, according to a research letter published in the December 6 issue of the Annals of Internal Medicine. The letter reports findings from a survey conducted by the American College of Physicians, which defines “high-value” interventions as those whose potential benefits outweigh the potential harms and costs.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.